Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cryptococcus uniguttulatus

Cryptococcus uniguttulatus CASE-LETTER which was confirmed by an outside reference laboratory Cryptococcus uniguttulatus Meningitis (Quest Diagnostics, Madison, MJ). Magnetic resonance imag- ing of the brain showed no evidence of parenchymal disease or hydrocephalus. The patient received 4 days of intravenous liposomal amphotericin B (5 mg/kg daily) with rapid improvement in on–neoformans cryptococci are generally regarded as her headache and nausea. Oral fluconazole 400 mg twice N saprophytes and are rarely reported as human patho- daily was given at discharge and changed to voriconazole gens. Cryptococcus uniguttulatus is encountered less fre- after susceptibility test results were received (Table 1). After quently in humans than are C laurentii and C albidus.The 2 weeks of voriconazole treatment, repeat CSF fungal cul- latter species are rare causes of fungemia, pneumonia, cen- ture was negative and the pleocytosis had resolved. The tral nervous system (CNS) infections and of skin and lung patient completed 4 months of voriconazole therapy and abscesses. Cryptococci are found in the environment, has had no evidence of recurrence of cryptococcal infection mainly in soil and vegetation and also bird droppings. after 1 year. Human colonization with C uniguttulatus has been C uniguttulatus was first characterized in 1934 by Wol- reported. Immunosuppression plays http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of the Medical Sciences Wolters Kluwer Health

Cryptococcus uniguttulatus

American Journal of the Medical Sciences , Volume Publish Ahead of Print – Sep 1, 2015

Loading next page...
 
/lp/wolters-kluwer-health/cryptococcus-uniguttulatus-0WWNU6GQ6g

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2015 by the Southern Society for Clinical Investigation.
ISSN
0002-9629
eISSN
1538-2990
DOI
10.1097/MAJ.0000000000000564
pmid
26371608
Publisher site
See Article on Publisher Site

Abstract

CASE-LETTER which was confirmed by an outside reference laboratory Cryptococcus uniguttulatus Meningitis (Quest Diagnostics, Madison, MJ). Magnetic resonance imag- ing of the brain showed no evidence of parenchymal disease or hydrocephalus. The patient received 4 days of intravenous liposomal amphotericin B (5 mg/kg daily) with rapid improvement in on–neoformans cryptococci are generally regarded as her headache and nausea. Oral fluconazole 400 mg twice N saprophytes and are rarely reported as human patho- daily was given at discharge and changed to voriconazole gens. Cryptococcus uniguttulatus is encountered less fre- after susceptibility test results were received (Table 1). After quently in humans than are C laurentii and C albidus.The 2 weeks of voriconazole treatment, repeat CSF fungal cul- latter species are rare causes of fungemia, pneumonia, cen- ture was negative and the pleocytosis had resolved. The tral nervous system (CNS) infections and of skin and lung patient completed 4 months of voriconazole therapy and abscesses. Cryptococci are found in the environment, has had no evidence of recurrence of cryptococcal infection mainly in soil and vegetation and also bird droppings. after 1 year. Human colonization with C uniguttulatus has been C uniguttulatus was first characterized in 1934 by Wol- reported. Immunosuppression plays

Journal

American Journal of the Medical SciencesWolters Kluwer Health

Published: Sep 1, 2015

References